Cortexyme Company
Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.
Funding Status:
IPO
Industry:
Biotechnology, Health Care, Medical, Pharmaceutical
Estimated Revenue:
$10M to $50M
Technology:
Gene therapy
Number Of Exists:
N/A
Headquarters:
South San Francisco, California, United States
Total Funding:
225000000
Last Funding Date:
2019
Last Funding Type:
Post-IPO Equity
Investor Type:
N/A
Employee Number:
11-50
Investors Number:
13
Investment Stage:
N/A
Founded Date:
2012